Evaluate Safety and Efficacy of Innovative Medical Devices for Colostomy Patients

NCT ID: NCT05466721

Last Updated: 2024-01-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

45 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-06-13

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The surgical ostomy process happens when it is necessary to open an organ (such as the intestine) in order to maintain a communication channel with the external environment. The need for ostomy surgery can happen as a result of illness, genetic factors, or trauma. Despite the extensive improvements in colorectal surgery, in case there is a need for total or partial extraction and exteriorization of the large intestine (colostomy), it is often necessary to perform a stoma that connects the end of the preserved intestine to the skin, in which cases it is necessary to place a a colostomy bag for stool collection. Thus, there is a substantial number of patients who need to live with a permanent abdominal stoma that significantly affects their quality of life, implying significant changes, both physical and social. It will then be necessary for patients to adjust their daily routines in order to deal with stoma care.

The primary objective of this study is to evaluate the Hydrustoma C3 medical devices (plate C3, capsule C3, night bag C3) in terms of its efficacy and safety as colostomy devices. It is also a primary objective of this study to compare the health-related quality of life in patients with colostomy when using a control and Hydrustoma C3 devices.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colostomy Stoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Hydrustoma C3

The participant will use the Hydrustoma C3 devices for 14 days and then switch into the control device for another 14 days.

Group Type EXPERIMENTAL

Hydrustoma C3

Intervention Type DEVICE

The participant will use the device for 14 days.

Coloplast Alterna

Intervention Type DEVICE

The participant will use the device for 14 days.

Coloplast Alterna

The participant will use the control devices for 14 days and then switch into the Hydrustoma C3 devices for another 14 days.

Group Type OTHER

Hydrustoma C3

Intervention Type DEVICE

The participant will use the device for 14 days.

Coloplast Alterna

Intervention Type DEVICE

The participant will use the device for 14 days.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hydrustoma C3

The participant will use the device for 14 days.

Intervention Type DEVICE

Coloplast Alterna

The participant will use the device for 14 days.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Written informed consent;
* Male and Female patients;
* Adult aged ≥ 18;
* Descending and sigmoid colostomy created more than 3 months previously to the beginning of the study;
* Having formed stool and using a flat ostomy appliance;
* Able to understand the study procedures and fill questionaries;
* Able to apply and remove the ostomy device autonomously.

Exclusion Criteria

* Repeated experiences of leakage with the usual ostomy device,
* Chronically liquid stools,
* Peristomal skin disorders,
* Known allergic reactions to components of the device,
* Receiving chemotherapy, radiation therapy or steroids in the previous month
Minimum Eligible Age

18 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hydrumedical

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Palmira Peixoto

Role: PRINCIPAL_INVESTIGATOR

Hospital de Braga

Paula Costa

Role: PRINCIPAL_INVESTIGATOR

Hospital Da Senhora Da Oliveira - Guimarães

Liliana Miranda

Role: PRINCIPAL_INVESTIGATOR

Hospital Centre Hospitalar de Trás-os-Montes e Alto Douro

Sara Costa

Role: PRINCIPAL_INVESTIGATOR

Centro Hospitalar de Entre o Douro e Vouga

Glória Gonçalves

Role: PRINCIPAL_INVESTIGATOR

Centro Hospitalar de Vila Nova de Gaia/Espinho

Carla Nunes

Role: PRINCIPAL_INVESTIGATOR

Centro Hospitalar do Tâmega e Sousa

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Da Senhora Da Oliveira - Guimarães

Guimarães, Braga District, Portugal

Site Status

Hospital de Braga

Braga, , Portugal

Site Status

Centro Hospitalar do Tâmega e Sousa

Penafiel, , Portugal

Site Status

Centro Hospitalar de Entre o Douro e Vouga

Santa Maria da Feira, , Portugal

Site Status

Centro Hospitalar de Vila Nova de Gaia/Espinho

Vila Nova de Gaia, , Portugal

Site Status

Centro Hospitalar de Trás-os-Montes e Alto Douro

Vila Real, , Portugal

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Portugal

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HydrustomaC3

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.